Hi, what are you looking for?
– A federal judge in Virginia ruled that the patent for Pfizer’s Celebrex expires in May. – A US federal judge in Virginia has...
– The company does not admit to charges of paying a psychiatrist to prescribe Clozapine. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) does not admit that...
– According to IMS data Xeloda made by Genentech, had $754 million in US sales in 2013. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA)...
– Abravanel’s is the first senior departure from Teva since Erez Vigodman became CEO. – – In the first departure from the senior management...
– Teva has 180 days of marketing exclusivity for generic Evista, which had 2013 US sales of $824 million. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)...
– The first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. –...
– Teva will receive $72 million from future sales or from the proceeds of an exit, if any. Diapep277 Slowing the Progression of Type 1...
– (Was Originally Published at Knowlegde@Wharton) – On 11 February, when Erez Vigodman stepped into the corner office at Teva Pharmaceutical Industries, he didn’t come...
– Synribo received provisional approval in 2012 subject to additional clinic trial data. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that the U.S. Food and Drug...
– Following the sale, Phillip Frost still owns Teva shares worth more than $500 million. – Phillip Frost / Getty – Teva Pharmaceutical Industries...